Samples of Popular Diabetes Drug Contain Potential Carcinogen, F.D.A. Says
Testing found nitrosamine contamination in some samples of Januvia, but regulators will allow Merck to continue selling the drug for now.
Testing found nitrosamine contamination in some samples of Januvia, but regulators will allow Merck to continue selling the drug for now.
The antiviral pills, plentiful in the United States, are scarce overseas. Health groups and the White House want to expand access but face obstacles that […]
The antiviral pills, plentiful in the United States, are scarce overseas. Health groups and the White House want to expand access but face obstacles that […]
The antiviral pills, plentiful in the United States, are scarce overseas. Health groups and the White House want to expand access but face obstacles that […]
The F.D.A. said the drug should be prescribed mainly when other treatments were “not accessible or clinically appropriate.”
The F.D.A. said the drug should be prescribed mainly when other treatments were “not accessible or clinically appropriate.”
The F.D.A. said the drug should be prescribed mainly when other treatments were “not accessible or clinically appropriate.”
The F.D.A. said the drug should be prescribed mainly when other treatments were “not accessible or clinically appropriate.”
The F.D.A. said the drug should be prescribed mainly when other treatments were “not accessible or clinically appropriate.”
The F.D.A. said the drug should be prescribed mainly when other treatments were “not accessible or clinically appropriate.”
The treatment, called Paxlovid, is likely to work against Omicron and could be available in the United States before the end of the year.
The treatment, called Paxlovid, is likely to work against Omicron and could be available in the United States before the end of the year.
Some laboratory studies suggest that molnupiravir can insert errors in DNA, which could in theory harm a developing fetus, sperm cells or children.
Some laboratory studies suggest that molnupiravir can insert errors in DNA, which could in theory harm a developing fetus, sperm cells or children.
Some laboratory studies suggest that molnupiravir can insert errors in DNA, which could in theory harm a developing fetus, sperm cells or children.
Merck y Pfizer están por presentar sus pastillas de prescripción para tratar la COVID-19. Vienen más fármacos en camino.
Merck y Pfizer están por presentar sus pastillas de prescripción para tratar la COVID-19. Vienen más fármacos en camino.
Merck y Pfizer están por presentar sus pastillas de prescripción para tratar la COVID-19. Vienen más fármacos en camino.
Merck and Pfizer will soon debut prescription pills to treat Covid-19. And more drugs are on the way.
Merck and Pfizer will soon debut prescription pills to treat Covid-19. And more drugs are on the way.
The treatment, known as molnupiravir, could be authorized in the United States within days, and available within weeks, if the F.D.A. follows the committee’s recommendation.
The treatment, known as molnupiravir, could be authorized in the United States within days, and available within weeks, if the F.D.A. follows the committee’s recommendation.
The treatment, known as molnupiravir, could be authorized in the United States within days, and available within weeks, if the F.D.A. follows the committee’s recommendation.
The pills must be given early in the course of infection, which means access to timely, accurate test results will be crucial.
The pills must be given early in the course of infection, which means access to timely, accurate test results will be crucial.
The pills must be given early in the course of infection, which means access to timely, accurate test results will be crucial.
The pills must be given early in the course of infection, which means access to timely, accurate test results will be crucial.
The pills must be given early in the course of infection, which means access to timely, accurate test results will be crucial.
The antiviral drugs have helped inspire hope among senior administration officials that the United States will be able to curb the devastating toll from the […]
The antiviral drugs have helped inspire hope among senior administration officials that the United States will be able to curb the devastating toll from the […]
The antiviral drugs have helped inspire hope among senior administration officials that the United States will be able to curb the devastating toll from the […]
The antiviral drugs have helped inspire hope among senior administration officials that the United States will be able to curb the devastating toll from the […]
Pfizer’s is the second pill to show effectiveness against Covid-19, and it is the first purpose-built to attack the virus that causes the disease.
The antiviral drugs have helped inspire hope among senior administration officials that the United States will be able to curb the devastating toll from the […]
The company announced a deal that could help significantly expand access to the Covid-19 treatment, but the agreement excludes a number of countries hit hard […]
Pfizer’s is the second pill to show effectiveness against Covid-19, and it is the first purpose-built to attack the virus that causes the disease.
Pfizer’s is the second pill to show effectiveness against Covid-19, and it is the first purpose-built to attack the virus that causes the disease.
Pfizer’s is the second pill to show effectiveness against Covid-19, and it is the first purpose-built to attack the virus that causes the disease.
The authorization of Merck’s easy-to-use Covid treatment, molnupiravir, is a step toward taming the pandemic.
The authorization of Merck’s easy-to-use Covid treatment, molnupiravir, is a step toward taming the pandemic.
The authorization of Merck’s easy-to-use Covid treatment, molnupiravir, is a step toward taming the pandemic.
The company announced a licensing deal that will allow the drug, molnupiravir, to be made and sold cheaply in 105 developing nations.
The company announced a licensing deal that will allow the drug, molnupiravir, to be made and sold cheaply in 105 developing nations.
Regulatory hurdles and supply chain issues could slow efforts to produce generic versions of Merck’s antiviral molnupiravir for developing nations, despite licensing agreements.
Regulatory hurdles and supply chain issues could slow efforts to produce generic versions of Merck’s antiviral molnupiravir for developing nations, despite licensing agreements.
Merck has taken a step to make its antiviral pill available in poor nations, but many obstacles remain for broad access to coronavirus drugs.
Merck has taken a step to make its antiviral pill available in poor nations, but many obstacles remain for broad access to coronavirus drugs.
Merck has taken a step to make its antiviral pill available in poor nations, but many obstacles remain for broad access to coronavirus drugs.
The company is seeking federal sign-off for the pill to be given to high-risk people sick with Covid. Tens of millions of Americans could be […]
The company is seeking federal sign-off for the pill to be given to high-risk people sick with Covid. Tens of millions of Americans could be […]
The company is seeking federal sign-off for the pill to be given to high-risk people sick with Covid. Tens of millions of Americans could be […]
The company is seeking federal sign-off for the pill to be given to high-risk people sick with Covid. Tens of millions of Americans could be […]
The home treatment, molnupiravir, is said by the company to potentially halve the risk of hospitalization and death from the virus.
The home treatment, molnupiravir, is said by the company to potentially halve the risk of hospitalization and death from the virus.
The home treatment, molnupiravir, is said by the company to potentially halve the risk of hospitalization and death from the virus.
The company is seeking authorization for the pill to be given to high-risk people sick with Covid. Tens of millions of Americans could be eligible.
The home treatment, molnupiravir, is said by the company to potentially halve the risk of hospitalization and death from the virus.
Las píldoras son eficaces y relativamente baratas, pero es poco probable que estén disponibles para todos los enfermos de covid.
Las píldoras son eficaces y relativamente baratas, pero es poco probable que estén disponibles para todos los enfermos de covid.
Las píldoras son eficaces y relativamente baratas, pero es poco probable que estén disponibles para todos los enfermos de covid.
President Biden’s Covid adviser also says it is “too soon to tell” if the Delta surge will decline enough to allow safe gatherings around the […]
The drug maker will seek authorization for molnupiravir, the first drug of its kind for Covid. Experts said such pills could be a powerful tool […]
The pills are effective and relatively cheap, but they are unlikely to be available for everyone with Covid.
The drug maker will seek authorization for molnupiravir, the first drug of its kind for Covid. Experts said such pills could be a powerful tool […]
The drug has spared hundreds of millions of Africans from serious parasites, but clinical trials have repeatedly failed to show that it is effective against […]
The move brings the total number of Johnson & Johnson doses made at the troubled plant and cleared by the F.D.A. to roughly 40 million.
The move brings the total number of Johnson & Johnson doses made at the troubled plant and cleared by the F.D.A. to roughly 40 million.
The move brings the total number of Johnson & Johnson doses made at the troubled plant and cleared by the F.D.A. to roughly 40 million.
A new $3.2 billion program will support the development of antiviral pills, which could start arriving by the end of this year.
The pharmaceutical giant Merck & Co. agreed to help manufacture Johnson & Johnson’s coronavirus vaccine, in a deal partly brokered by the White House.
After ending its own Covid-19 vaccine trials, the company said that it was actively discussing with governments how to help its competitors make their shots.
After ending its own Covid-19 vaccine trials, the company said that it was actively discussing with governments how to help its competitors make their shots.
After ending its own Covid-19 vaccine trials, the company said that it was actively discussing with governments how to help its competitors make their shots.
After ending its own Covid-19 vaccine trials, the company said that it was actively discussing with governments how to help its competitors make their shots.
After ending its own Covid-19 vaccine trials, the company said that it is actively discussing with governments how to help its competitors make their shots.
After ending its own Covid-19 vaccine trials, the company said that it is actively discussing with governments how to help its competitors make their shots.
The Trump administration is discussing helping the drug maker get the raw materials it would need to produce tens of millions of extra doses of […]
Copyright © 2024 | WordPress Theme by MH Themes